Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464765 | SCV000559875 | benign | Adams-Oliver syndrome 5 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696908 | SCV000719224 | likely benign | not provided | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313214 | SCV000739402 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-07-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000660164 | SCV000782158 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000464765 | SCV002554411 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270520 | SCV002554412 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001696908 | SCV004162019 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001696908 | SCV001928182 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001696908 | SCV001966164 | likely benign | not provided | no assertion criteria provided | clinical testing |